Department of adults Psychiatry, Hôpital Pitié-Salpêtrière, Paris, France.
Depress Anxiety. 2012 Jan;29(1):62-70. doi: 10.1002/da.20851. Epub 2011 Jul 18.
Fear of blushing (FB) in front of other people is a frequent and potentially incapacitating problem, but is not yet described as a specific diagnosis in psychiatric classifications. This can be explained by a lack of comparative studies with other forms of social anxiety disorder (SAD). Our aim was thus to explore the specificity of FB in patients with SAD.
SAD patients with FB but without other social threat (n = 142), the majority of whom were referred by a department of surgery after an initial request of sympathetic block for facial blushing, were compared to SAD patients with FB and other associated social fears (n = 97), and to SAD patients without FB (n = 190). They were assessed and compared with a structured diagnostic interview for DSM-IV and various scales measuring social anxiety, other anxiety and depressive symptoms, impairment and personality traits.
The group with pure FB showed specific profiles when compared with the two other groups: later age of onset, less comorbidity, lower behavioral and temperamental inhibition, and higher self-esteem. However, their levels of social anxiety and impairment were high. No important differences appeared between the two other groups.
The specificity of FB should be considered in the social anxiety spectrum, and could be viewed either as a SAD subtype or as SAD form secondary to facial blushing. Further epidemiological and therapeutic studies on this disorder are necessary.
在他人面前脸红恐惧(FB)是一种常见且潜在使人丧失能力的问题,但在精神科分类中尚未被描述为特定的诊断。这可以用缺乏与其他形式的社交焦虑障碍(SAD)的比较研究来解释。因此,我们的目的是探讨 SAD 患者中 FB 的特异性。
我们将 142 名患有 FB 但无其他社交威胁的 SAD 患者(大多数是由外科部门转介的,这些患者最初因面部脸红要求交感神经阻滞)与 97 名患有 FB 和其他相关社交恐惧的 SAD 患者以及 190 名无 FB 的 SAD 患者进行了比较。他们接受了 DSM-IV 结构化诊断访谈以及各种衡量社交焦虑、其他焦虑和抑郁症状、障碍和人格特质的量表评估和比较。
与其他两组相比,单纯 FB 组表现出特定的特征:发病年龄较晚、合并症较少、行为和气质抑制较低、自尊心较高。然而,他们的社交焦虑和障碍水平很高。另外两组之间没有出现重要差异。
在社交焦虑谱中应考虑 FB 的特异性,它可以被视为 SAD 的一种亚型,也可以是继发于脸红的 SAD 形式。有必要对这种疾病进行进一步的流行病学和治疗研究。